APEN - エルパス （Apollo Endosurgery Inc.） エルパスAPENのチャート
APENの企業情報
| symbol | APEN |
|---|---|
| 会社名 | Apollo Endosurgery Inc （エルパス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Medical/Dental Instruments |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 Apollo Endosurgery Inc. formerly Lpath Inc. is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity as well as other gastrointestinal disorders. The Company''s device-based therapies are an alternative to invasive surgical procedures. The Company offers products in over 80 countries. The Company''s products include ORBERA LAP-BAND and OverStitch. The Company''s product ORBERA is a gastric balloon. The ORBERA Intragastric Balloon System is a weight loss aid for adults suffering from obesity. The LAP-BAND System is a minimally invasive procedure that offers weight loss. The LAP-BAND System is indicated for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables advanced endoscopic surgery by allowing physicians to place full-thickness sutures through a flexible endoscope. OverStitch offers solutions for defects in both the upper and lower gastrointestinal tract. エルパスは、米国のバイオテクノロジ―企業。｢lipidomic｣ベ―スの治療抗体の発見と開発に焦点を当てたる｡｢ iSONEP｣は､sonepcizumabの眼の製剤。｢ASONEP｣は、癌の様々な腫瘍タイプを治療するために処方されsonepcizumabの全身性製剤、および腎細胞癌を有する患者の治療薬。 |
| 本社所在地 | 1120 S. Capital of Texas Highway Building 1 Suite #300 Austin TX 78746 USA |
| 代表者氏名 | Richard J. Meelia リチャード・J・ミエリア |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 512-279-5100 |
| 設立年月日 | － |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 213人 |
| url | www.apolloendo.com |
| nasdaq_url | https://www.nasdaq.com/symbol/apen |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -15.77900 |
| 終値（lastsale） | 6.9199 |
| 時価総額（marketcap） | 151399772.4304 |
| 時価総額 | 時価総額（百万ドル） 148.33890 |
| 売上高 | 売上高（百万ドル） 64.21500 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 147.26790 |
| 当期純利益 | 当期純利益（百万ドル） -29.89200 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Apollo Endosurgery Inc revenues decreased less than 1% to $31.5M. Net loss increased 17% to $17.7M. Revenues reflect Endo-bariatric segment increase of 25% to $21.1M Other segment increase of 49% to $543K also reflect Surgical segment decrease of 32% to $9.9M United States segment decrease of 14% to $14.5M. Higher net loss reflects Research and development increase of 32% to $5.6M |
APENのテクニカル分析
APENのニュース
38 Stocks Moving in Monday's Pre-Market Session 2021/03/01 07:03:00 Benzinga
Gainers Apollo Endosurgery, Inc. (NASDAQ: APEN) shares rose 116% to $10.13 in pre-market trading after the company said it received FDA breakthrough device …
Weight Loss Management Market to Witness Huge Growth by 2027| Key Players are Cybex International, Ediets.Com, Equinox, Amer Sports, Apollo Endosurgery, Jenny Craig, Johnson Health Technology, Atkins Nutritionals, Brunswick Corporation, Medtronic, Herbali 2021/01/12 14:22:36 OpenPR
ReportsnReports.com the exclusive leading provider of market research reports published research report on “Global Weight Loss Management Market Research Report 2021”. The Global Weight Loss Management Market Report 2021 is a professional and in-depth study on the current state of the
Apollo Endosurgery to Present at HC Wainwright Bioconnect Conference - Stocks News Feed 2021/01/05 21:38:59 Stocks News Feed
AUSTIN, TX / ACCESSWIRE / January 5, 2021 / Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today announced that it will participate in the H.C. Wainwright Bioconnect 2021 Conference taking place virtually January 11-14, 2021. Management will provide a pre-recorded presentation which will be… Read More »Apollo Endosurgery to Present at HC Wainwright Bioconnect Conference
New Comprehensive Report on Obesity Intervention Devices Market 2020-2027| EnteroMedics, Apollo Endosurgery, Cousin Biotech, Aspire Bariatrics, Obalon Therapeutics 2020/11/23 12:44:49 OpenPR
HealthCare Intelligence Markets unravels its new study titled Obesity Intervention Devices Market. Effective exploratory techniques such as qualitative and quantitative analysis have been used to discover accurate data. For an effective business outlook, it studies North America, Latin America, Asia-Pacific,
Apollo Endosurgery EPS beats by $0.10, beats on revenue (NASDAQ:APEN) 2020/11/05 21:59:30 Seeking Alpha
Apollo Endosurgery (NASDAQ:APEN): Q3 GAAP EPS of -$0.11 beats by $0.10. Revenue of $12.83M (+13.9% Y/Y) beats by $2.85M. Press Release
New Comprehensive Report on Obesity Intervention Devices Market 2020-2027| EnteroMedics, Apollo Endosurgery, Cousin Biotech, Aspire Bariatrics, Obalon Therapeutics 2020/11/23 12:44:49 OpenPR
HealthCare Intelligence Markets unravels its new study titled Obesity Intervention Devices Market. Effective exploratory techniques such as qualitative and quantitative analysis have been used to discover accurate data. For an effective business outlook, it studies North America, Latin America, Asia-Pacific,
Apollo Endosurgery EPS beats by $0.10, beats on revenue (NASDAQ:APEN) 2020/11/05 21:59:30 Seeking Alpha
Apollo Endosurgery (NASDAQ:APEN): Q3 GAAP EPS of -$0.11 beats by $0.10. Revenue of $12.83M (+13.9% Y/Y) beats by $2.85M. Press Release
Bariatric Surgery Devices Industry 2020 With Covid-19 Impact on Market Size, Share, Revenue, Latest Trends, Business Boosting Strategies| Medtronic plc., Intuitive Surgical Inc., Apollo Endosurgery, Reshape Lifesciences, Olympus 2020/11/03 08:27:05 OpenPR
DBMR published a new study on the Global Bariatric Surgery Devices Market exclusive insights, Opportunities and revenue size estimation and growth factors. Bariatric Surgery Devices Market Report considers important aspects of the market that consist of historic data, present market
Endoluminal Suturing Devices Market Trends & Opportunities with Forecast 2020 - 2027 | Apollo Endosurgery Inc, Johnson & Johnson Services Inc, and Medtronic 2020/10/27 12:10:43 OpenPR
Endoluminal Suturing Devices Market research report highlights the most important market insights that take business to the highest level of growth and success. The research, analysis and estimations about the market have been performed with the reliable knowledge in this
Here's how 4 top law firms have been taking VC-style stakes in their own clients including Peloton and Snowflake — and why many of these lucrative bets fly under the radar 2020/10/09 14:35:54 Business Insider
Summary List Placement Lawyers at Cooley reportedly made around $150 million when the firm's client Snowflake went public. It wasn't the first time that Big Law attorneys struck it big investing in a client, and it probably won't be the last. Venture capital-style investments by law firms and their partners go back decades, with Cooley and firms including Wilson Sonsini and now-defunct Venture Law Group reported to take stakes in emerging companies. Before the dot-com bust, some of those stakes were valued in the tens of millions of dollars. Investing in clients has always been somewhat fraught, with some legal ethics professionals saying it can cloud a lawyer's professional judgment and lead to conflicts. That's why firms that do take a stake in clients often take a relatively small one, and often just for part of the fees that they charge, with the rest paid in cash, according to published accounts . Read more: Snowflake's mega IPO resulted in more than $100 million in fees for investment banks.
New Comprehensive Report on Obesity Intervention Devices Market 2020-2027| EnteroMedics, Apollo Endosurgery, Cousin Biotech, Aspire Bariatrics, Obalon Therapeutics 2020/11/23 12:44:49 OpenPR
HealthCare Intelligence Markets unravels its new study titled Obesity Intervention Devices Market. Effective exploratory techniques such as qualitative and quantitative analysis have been used to discover accurate data. For an effective business outlook, it studies North America, Latin America, Asia-Pacific,
Apollo Endosurgery EPS beats by $0.10, beats on revenue (NASDAQ:APEN) 2020/11/05 21:59:30 Seeking Alpha
Apollo Endosurgery (NASDAQ:APEN): Q3 GAAP EPS of -$0.11 beats by $0.10. Revenue of $12.83M (+13.9% Y/Y) beats by $2.85M. Press Release
Bariatric Surgery Devices Industry 2020 With Covid-19 Impact on Market Size, Share, Revenue, Latest Trends, Business Boosting Strategies| Medtronic plc., Intuitive Surgical Inc., Apollo Endosurgery, Reshape Lifesciences, Olympus 2020/11/03 08:27:05 OpenPR
DBMR published a new study on the Global Bariatric Surgery Devices Market exclusive insights, Opportunities and revenue size estimation and growth factors. Bariatric Surgery Devices Market Report considers important aspects of the market that consist of historic data, present market
Endoluminal Suturing Devices Market Trends & Opportunities with Forecast 2020 - 2027 | Apollo Endosurgery Inc, Johnson & Johnson Services Inc, and Medtronic 2020/10/27 12:10:43 OpenPR
Endoluminal Suturing Devices Market research report highlights the most important market insights that take business to the highest level of growth and success. The research, analysis and estimations about the market have been performed with the reliable knowledge in this
Here's how 4 top law firms have been taking VC-style stakes in their own clients including Peloton and Snowflake — and why many of these lucrative bets fly under the radar 2020/10/09 14:35:54 Business Insider
Summary List Placement Lawyers at Cooley reportedly made around $150 million when the firm's client Snowflake went public. It wasn't the first time that Big Law attorneys struck it big investing in a client, and it probably won't be the last. Venture capital-style investments by law firms and their partners go back decades, with Cooley and firms including Wilson Sonsini and now-defunct Venture Law Group reported to take stakes in emerging companies. Before the dot-com bust, some of those stakes were valued in the tens of millions of dollars. Investing in clients has always been somewhat fraught, with some legal ethics professionals saying it can cloud a lawyer's professional judgment and lead to conflicts. That's why firms that do take a stake in clients often take a relatively small one, and often just for part of the fees that they charge, with the rest paid in cash, according to published accounts . Read more: Snowflake's mega IPO resulted in more than $100 million in fees for investment banks.